Atom Investors LP Coherus Bio Sciences, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.02 - $3.14 $79,111 - $122,974	39,164 New	39,164 $93,000
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $119,643 - $270,116	-20,417 Reduced 66.94%	10,085 $73,000
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $333,081 - $500,537	30,502 New	30,502 $394,000
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $505,627 - $671,366	-35,040 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $408,916 - $789,451	35,040 New	35,040 $568,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.